Sarepta Therapeutics Inc (NASDAQ: SRPT) stock closed at $119.77 on 1/9/24 after a major increase of 16.7%. Moreover, this advance was accompanied by exceptionally high trading volume at 341% of normal. The stock has risen 24.2% during the last week but has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to exceed the cost of capital, SRPT is expected to be a major Value Builder.
Sarepta Therapeutics has a current Value Trend Rating of C (Low Neutral). This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. Sarepta Therapeutics has a neutral Appreciation Score of 56 and a slightly negative Power Rating of 33, triggering the Low Neutral Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment